Watch Ticker

Enlivex Therapeutics Ltd. Ordinary Shares

Go to Enlivex Therapeutics Ltd. Ordinary Shares Website

$1.39

-0.09 (-6.08%)

Live

Previous Close

$1.48

Day Range

$1.34 - $1.5299

Previous Day Range

$1.47 - $1.66

Market Cap

$34.6 million USD

Day Vol.

523499

Previous Day Vol.

819597

Currency

USD

Primary Exchange

Nasdaq

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy t...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Enlivex Receives Notice of Allowance for Japanese Patent Application Covering the Use of Allocetra™ in Patients with Osteoarthritis

Enlivex Therapeutics received a notice of allowance for a Japanese patent application covering the use of its Allocetra™ product in treating osteoarthritis, a common and debilitating condition with limited treatment options.

Related tickers: ENLV.

Read Full Article

Enlivex Therapeutics Ltd - Enlivex Announces Positive Interim Data Readout from a Phase I/II Trial Evaluating Allocetra in End-Stage Knee Osteoarthritis

Key Highlights

Related tickers: ENLV.

Read Full Article

Trending Tickers

Please sign in to view